Douleur chronique cancéreuse et analgésie intrathécale : expérience de trois centres de lutte contre le cancer

[1]  M. Saulino,et al.  Polyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel , 2012, Neuromodulation : journal of the International Neuromodulation Society.

[2]  C. Rochlitz,et al.  Serious Complications Associated with External Intrathecal Catheters Used in Cancer Pain Patients: A Systematic Review and Meta-analysis , 2009, Anesthesiology.

[3]  F. De Conno,et al.  Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  S. Hassenbusch,et al.  Polyanalgesic Consensus Conference 2007: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel , 2007, Neuromodulation : journal of the International Neuromodulation Society.

[5]  J. Marty,et al.  Douleurs cancéreuses par excès de nociception chez l'adulte : mise au point sur les recommandations concernant les traitements antalgiques médicamenteux , 2007 .

[6]  X. Ruan.  Drug-related side effects of long-term intrathecal morphine therapy. , 2007, Pain physician.

[7]  Wen Ling Peng,et al.  Multidisciplinary management of cancer pain: a longitudinal retrospective study on a cohort of end-stage cancer patients. , 2006, Journal of pain and symptom management.

[8]  M. Wallace.  Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain , 2006, Expert review of neurotherapeutics.

[9]  L. Webster,et al.  A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. , 2006, Journal of pain and symptom management.

[10]  J. Bailes,et al.  A review of intrathecal morphine therapy related granulomas , 2006, European journal of pain.

[11]  Gerhard Friehs,et al.  Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices. , 2005, The journal of supportive oncology.

[12]  H. Kress,et al.  Long-term intrathecal S(+)-ketamine in a patient with cancer-related neuropathic pain. , 2005, British journal of anaesthesia.

[13]  D. McGuire,et al.  Occurrence of cancer pain. , 2004, Journal of the National Cancer Institute. Monographs.

[14]  S. Hassenbusch,et al.  Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel. , 2004, Journal of pain and symptom management.

[15]  M. Byas-Smith,et al.  Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial. , 2004, JAMA.

[16]  R. Rauck,et al.  Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain. , 2003, Journal of Pain.

[17]  R. Rosenquist,et al.  Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations. , 2003, Journal of pain and symptom management.

[18]  K. Omote,et al.  Antihyperalgesic and Side Effects of Intrathecal Clonidine and Tizanidine in a Rat Model of Neuropathic Pain , 2003, Anesthesiology.

[19]  Thomas J. Smith,et al.  How to use implantable intrathecal drug delivery systems for refractory cancer pain. , 2003, The journal of supportive oncology.

[20]  Thomas J. Smith,et al.  Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  H. Kress,et al.  The long-term antinociceptive effect of intrathecal S(+)-ketamine in a patient with established morphine tolerance. , 2001, Anesthesia and analgesia.

[22]  L. Radbruch,et al.  Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology , 2001, Pain.

[23]  C. Olegård,et al.  Comparison of 0.5% Intrathecal Bupivacaine With 0.5% Intrathecal Ropivacaine in the Treatment of Refractory Cancer and Noncancer Pain Conditions: Results From a Prospective, Crossover, Double-Blind, Randomized Study , 2000, Regional Anesthesia & Pain Medicine.

[24]  R. Miguel,et al.  Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder? , 2000, Cancer control : journal of the Moffitt Cancer Center.

[25]  J. van Egmond,et al.  Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients. , 1999, The Clinical journal of pain.

[26]  A. Caraceni,et al.  An international survey of cancer pain characteristics and syndromes , 1999, PAIN.

[27]  J. Boggan,et al.  Intrathecal morphine delivered via subcutaneous pump for intractable cancer pain: a review of the literature. , 1999, Surgical neurology.

[28]  S. Hassenbusch,et al.  Clinical realities and economic considerations: economics of intrathecal therapy. , 1997, Journal of pain and symptom management.

[29]  A. Vainio,et al.  Long‐term intrathecal infusion of morphine in the home care of patients with advanced cancer , 1997, Acta anaesthesiologica Scandinavica.

[30]  R. Penn,et al.  Intraspinal morphine for chronic pain: a retrospective, multicenter study. , 1996, Journal of pain and symptom management.

[31]  C. Cleeland,et al.  Multicentre study of cancer pain and its treatment in France , 1995, BMJ.

[32]  G. Rolly,et al.  Spinal analgesia in terminal care: risk versus benefit. , 1994, Journal of pain and symptom management.

[33]  F. Magora,et al.  EPIDURAL MORPHINE IN TREATMENT OF PAIN , 1979, The Lancet.

[34]  John E. Thomas,et al.  Pain relief by intrathecally applied morphine in man. , 1979, Anesthesiology.

[35]  J. Salomon,et al.  Immunostimulants in primary hepatomas , 1975, The Lancet.

[36]  J. Bonica,et al.  THE MANAGEMENT OF PAIN , 1954 .